We represented AmSurg Holdings, Inc. in a dispute with a group of physicians seeking to invalidate a non-compete provision that was a material feature of a highly profitable surgery center partnership in California. The dispute began when the surgery center lost its lease, and the parties were required to find a replacement location. The physicians tried to leverage the lease termination as a way to cut AmSurg out of the business, and the surgery center was ultimately forced to close as a result of their actions. The physicians then sued to get free of the non-compete obligations. Following months of contentious discovery, the parties had a two-week arbitration hearing in Los Angeles. The arbitration panel issued its decision in March 2016, ruling in AmSurg’s favor on every claim. The panel also awarded AmSurg $9 million in damages. In late 2016, the physicians filed two federal lawsuits seeking to block or overturn the arbitration panel’s decision. We beat back each of those efforts, and, in mid-2017, the federal court in Nashville affirmed the arbitration award in full. The federal court also awarded pre- and post-judgment interest, which added an additional $500,000 to AmSurg’s recovery. The client is very pleased with the result, which will serve as valuable precedent in similar disputes in the future. AmSurg Holdings, Inc., which is now a subsidiary of Envision Healthcare Corp. (NYSE: EVHC) acquires, develops and operates ambulatory surgery centers in partnership with physician practice groups throughout the United States.
AmSurg Awarded Full Arbitration Award Amount in Physician Group Dispute
You Also May Be Interested In:
Representation of Bankruptcy Trustee in Director and Officer Litigation Results in Lucrative Confidential Settlement for the Benefit of Trust Beneficiaries
Represented a Liquidating Trustee in connection with the pursuit of potential director and officer claims arising out of the Chapter 11 bankruptcy of a $700 million hospitality company, resulting in a large confidential settlement for the Trust
Representation of Investor Group Leads to $3 Million Settlement Against Global Financial Services Company
Represented a group of investors and former employees with claims against a global financial services company relating to a stock repurchase, resulting in a settlement valued at approximately $3 million
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.